Boxer Capital, LLC’s Ultragenyx Pharmaceutical In Position
Does Boxer Capital, LLC own Ultragenyx Pharmaceutical In (RARE)? Not currently — the last reported position was 200.0K shares worth $15M in Q1 2022; the fund’s latest 13F (Q4 2024) no longer reports it.
Position Value
$15M
Q1 2022
Shares
200.0K
% of Portfolio
+0.75%
Quarters Held
2
position exited
Position History RARE
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of RARE.